Abbott

Gerência de Contas Estratégicas (Key Account Manager) - Divisão de Farmacêuticos Estabelecidos (EPD) - São Paulo/SP

Brazil

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Farmacêuticos, SaúdeIndustries

Requirements

Candidates should have experience in negotiating and developing, registering, and launching Abbott products with distributors and major retail pharmacy chains nationwide. A strong understanding of the pharmaceutical market, including tax and fiscal knowledge, is required. The role also demands assertiveness, commercial proactivity, and creativity in problem-solving. Experience managing business plans and working with various internal and client departments is also necessary.

Responsibilities

The Key Account Manager will be responsible for negotiating and selling Abbott products to major retail chains and national distributors, aiming to increase market share for brands by understanding client-specific strategies. This includes meeting monthly Net Sales targets, monitoring stock levels through market audits and client data, and developing Annual Customer Business Plans (ACBP) with trade marketing to drive sell-out. The role involves managing promotional actions, tracking store turnover and stock data, collaborating with Abbott departments and client teams, and adhering to company policies and codes of conduct.

Skills

Negociação
Desenvolvimento de negócios
Gestão de contas
Varejo farmacêutico
Distribuição

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters
1888Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.
Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.
Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.
Abbott's microfluidic devices streamline diagnostic processes efficiently.
Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.
Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.
Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI